The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregation in Vitro
- 23 September 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 52 (40) , 6925-6927
Abstract
α-Synuclein (α-Syn) aggregation is directly linked with Parkinson’s disease (PD) pathogenesis. Here, we analyzed the aggregation of newly discovered α-Syn missense mutant H50Q in vitro and found that this mutation significantly accelerates the aggregation and amyloid formation of α-Syn. This mutation, however, did not alter the overall secondary structure as suggested by two-dimensional nuclear magnetic resonance and circular dichroism spectroscopy. The initial oligomerization study by cross-linking and chromatographic techniques suggested that this mutant oligomerizes to an extent similar to that of the wild-type α-Syn protein. Understanding the aggregation mechanism of this H50Q mutant may help to establish the aggregation and phenotypic relationship of this novel mutant in PD.Keywords
This publication has 16 references indexed in Scilit:
- G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndromeAnnals of Neurology, 2013
- A novel α-synuclein missense mutation in Parkinson diseaseNeurology, 2013
- Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's diseaseMovement Disorders, 2013
- α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?Acta Neuropathologica, 2013
- The many faces of α-synuclein: from structure and toxicity to therapeutic targetNature Reviews Neuroscience, 2012
- In vivo demonstration that α-synuclein oligomers are toxicProceedings of the National Academy of Sciences, 2011
- Pre‐fibrillar α‐synuclein variants with impaired β‐structure increase neurotoxicity in Parkinson's disease modelsThe EMBO Journal, 2009
- THE BIOCHEMISTRY OF PARKINSON'S DISEASEAnnual Review of Biochemistry, 2005
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapyProceedings of the National Academy of Sciences, 2000